Literature DB >> 25270597

Should off-label drugs be included as comparators in pharmacoeconomic studies?

Surrey M Walton1, Glen T Schumock.   

Abstract

Mesh：

Year:  2014        PMID： 25270597     DOI： 10.1007/s40273-014-0222-2

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  14 in total

1.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

2.  What ever happened to FDAMA Section 114? A look back after 10 years.

Authors:  Peter J Neumann
Journal:  Value Health       Date:  2008-07-24       Impact factor: 5.725

3.  A trial of indication based prescribing of antihypertensive medications during computerized order entry to improve problem list documentation.

Authors:  Suzanne Falck; Sruthi Adimadhyam; David O Meltzer; Surrey M Walton; William L Galanter
Journal:  Int J Med Inform       Date:  2013-08-08       Impact factor: 4.046

4.  Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.

Authors:  David C Hoaglin; Neil Hawkins; Jeroen P Jansen; David A Scott; Robbin Itzler; Joseph C Cappelleri; Cornelis Boersma; David Thompson; Kay M Larholt; Mireya Diaz; Annabel Barrett
Journal:  Value Health       Date:  2011-06       Impact factor: 5.725

5.  Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.

Authors:  Richard P Paczynski; G Caleb Alexander; Vernon M Chinchilli; Stefan P Kruszewski
Journal:  Int J Risk Saf Med       Date:  2012-01-01

6.  Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development of reference models.

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Tracy Merlin
Journal:  Med Decis Making       Date:  2012-09-07       Impact factor: 2.583

7.  A trial of inpatient indication based prescribing during computerized order entry with medications commonly used off-label.

Authors:  S M Walton; W L Galanter; H Rosencranz; D Meltzer; R S Stafford; F Tiryaki; D Sarne
Journal:  Appl Clin Inform       Date:  2011-03-09       Impact factor: 2.342

8.  Increasing off-label use of antipsychotic medications in the United States, 1995-2008.

Authors:  G C Alexander; S A Gallagher; A Mascola; R M Moloney; R S Stafford
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-01-06       Impact factor: 2.890

9.  Prioritizing future research on off-label prescribing: results of a quantitative evaluation.

Authors:  Surrey M Walton; Glen T Schumock; Ky-Van Lee; G Caleb Alexander; David Meltzer; Randall S Stafford
Journal:  Pharmacotherapy       Date:  2008-12       Impact factor: 4.705

Review 10.  The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions.

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Marco Pellegrini; Carmelo De Gori; Gabriele Del Castillo; Nicola Giordano; Ranuccio Nuti
Journal:  Ther Clin Risk Manag       Date:  2014-08-13       Impact factor: 2.423
View more
  1 in total

1.  Assessment of Web-Based Consumer Reviews as a Resource for Drug Performance.

Authors:  Swarnaseetha Adusumalli; HueyTyng Lee; Qiangze Hoi; Si-Lin Koo; Iain Beehuat Tan; Pauline Crystal Ng
Journal:  J Med Internet Res       Date:  2015-08-28       Impact factor: 5.428
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.